JNJ vs ZBH
By Alex · Tickerpine
Johnson & Johnson vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | ZBH |
|---|---|---|
| Price | $273.14 | $100.24 |
| Market cap | $658.24B | $19.12B |
| P/E ratio | 31.7 | 24.5 |
| ROE | 25.74% | 6.41% |
| Profit margin | 21.48% | 9.48% |
| Revenue growth | 6.60% | 4.80% |
| Dividend yield | 1.96% | 0.95% |
| Beta | 0.23 | 0.46 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs ZBH in plain English
- JNJ is the bigger company — about 34.4× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 24.5 vs 31.7).
- JNJ earns a higher return on equity (26% vs 6%).
- JNJ is growing revenue faster (7% vs 5%).
- JNJ has the higher dividend yield (1.96% vs 0.95%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.